This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron, Fundació Privada Institut D'investigació, Institucio Catalana De Recerca I Estudis Avancats. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 7 
1 out of 1 
1 out of 93 
Years Active: 2019-2022
Title: Marie-Eve Beaulieu: Innovator in Cancer Treatment
Introduction
Marie-Eve Beaulieu is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of three patents, her work focuses on developing methods and compositions that aim to improve cancer therapies.
Latest Patents
Among her latest patents, one notable invention involves methods and compositions for the treatment of cancer. This invention relates to a polypeptide that comprises or consists of the polypeptide of SEQ ID NO: 1, wherein the residue X at position 89 is not a cysteine. This polypeptide and its functionally equivalent variants are intended for use in medicine, particularly in the prevention and/or treatment of cancer. Another significant patent is centered around a Myc dominant negative mutant, known as Omomyc, which is designed for use in medicine and for the prevention and/or treatment of cancer. This invention also includes a fusion protein comprising Omomyc and pharmaceutical compositions thereof.
Career Highlights
Marie-Eve Beaulieu has worked with esteemed organizations such as the Fundació Privada Institut D'Investigació Oncològica De Vall Hebron and the Fundació Privada Institut D'Investigació. Her career is marked by a commitment to advancing cancer research and developing effective treatment options.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Laura Soucek and Toni Jauset González. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Marie-Eve Beaulieu's innovative work in cancer treatment exemplifies her dedication to improving medical outcomes for patients. Her patents and collaborations reflect her significant impact on the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile